192 related articles for article (PubMed ID: 32916955)
21. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
22. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P
Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762
[TBL] [Abstract][Full Text] [Related]
23. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA expression profiling of Chinese follicular lymphoma by microarray: A preliminary study.
Pan Y; Guo Y; Luo Y; Li H; Xu Y
Int Immunopharmacol; 2016 Oct; 39():41-47. PubMed ID: 27409728
[TBL] [Abstract][Full Text] [Related]
25. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
26. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
[TBL] [Abstract][Full Text] [Related]
27. Identification of Circulating miRNAs Differentially Regulated by Opioid Treatment.
Toyama K; Kiyosawa N; Watanabe K; Ishizuka H
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926935
[TBL] [Abstract][Full Text] [Related]
28. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
[TBL] [Abstract][Full Text] [Related]
29. Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma.
Amodio N; Gallo Cantafio ME; Botta C; Agosti V; Federico C; Caracciolo D; Ronchetti D; Rossi M; Driessen C; Neri A; Tagliaferri P; Tassone P
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781685
[TBL] [Abstract][Full Text] [Related]
30. Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With Obesity and TNFα-Induced Insulin Resistance.
Lozano-Bartolomé J; Llauradó G; Portero-Otin M; Altuna-Coy A; Rojo-Martínez G; Vendrell J; Jorba R; Rodríguez-Gallego E; Chacón MR
J Clin Endocrinol Metab; 2018 Apr; 103(4):1447-1458. PubMed ID: 29409019
[TBL] [Abstract][Full Text] [Related]
31. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
Chen X; Shi K; Wang Y; Song M; Zhou W; Tu H; Lin Z
Oncotarget; 2015 Nov; 6(35):37544-56. PubMed ID: 26462034
[TBL] [Abstract][Full Text] [Related]
32. Preeclampsia: The Interplay Between Oxygen-Sensitive miRNAs and Erythropoietin.
Gusar V; Timofeeva A; Chagovets V; Kan N; Vasilchenko O; Prozorovskaya K; Ivanets T; Sukhikh G
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32093169
[TBL] [Abstract][Full Text] [Related]
33. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
Li C; Yin Y; Liu X; Xi X; Xue W; Qu Y
Oncotarget; 2017 Apr; 8(15):24564-24578. PubMed ID: 28445945
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine.
Cavalcante P; Mizrachi T; Barzago C; Scandiffio L; Bortone F; Bonanno S; Frangiamore R; Mantegazza R; Bernasconi P; Brenner T; Vaknin-Dembinsky A; Antozzi C
Pharmacol Res; 2019 Oct; 148():104388. PubMed ID: 31401213
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling.
Tang B; Xu A; Xu J; Huang H; Chen L; Su Y; Zhang L; Li J; Fan F; Deng J; Tang L; Sun C; Hu Y
Int J Cancer; 2018 Jan; 142(1):109-120. PubMed ID: 28905994
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data.
Satoh J; Kino Y; Niida S
Biomark Insights; 2015; 10():21-31. PubMed ID: 25922570
[TBL] [Abstract][Full Text] [Related]
38. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
39. A serum miRNA profile of human longevity: findings from the Baltimore Longitudinal Study of Aging (BLSA).
Smith-Vikos T; Liu Z; Parsons C; Gorospe M; Ferrucci L; Gill TM; Slack FJ
Aging (Albany NY); 2016 Nov; 8(11):2971-2987. PubMed ID: 27824314
[TBL] [Abstract][Full Text] [Related]
40. Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma.
Calsina B; Castro-Vega LJ; Torres-Pérez R; Inglada-Pérez L; Currás-Freixes M; Roldán-Romero JM; Mancikova V; Letón R; Remacha L; Santos M; Burnichon N; Lussey-Lepoutre C; Rapizzi E; Graña O; Álvarez-Escolá C; de Cubas AA; Lanillos J; Cordero-Barreal A; Martínez-Montes ÁM; Bellucci A; Amar L; Fernandes-Rosa FL; Calatayud M; Aller J; Lamas C; Sastre-Marcos J; Canu L; Korpershoek E; Timmers HJ; Lenders JW; Beuschlein F; Fassnacht-Capeller M; Eisenhofer G; Mannelli M; Al-Shahrour F; Favier J; Rodríguez-Antona C; Cascón A; Montero-Conde C; Gimenez-Roqueplo AP; Robledo M
Theranostics; 2019; 9(17):4946-4958. PubMed ID: 31410193
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]